7001 - 7010 of 8801 Results
Title
Year
-
OPENTitle: Toward the quantification of α-synuclein aggregates with digital seed amplification assaysJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 121Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.2312031121Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10801878/pdf/pnas.202312031.pdfCitation Count: 14
-
OPENTitle: A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synucleinJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1186/s13024-016-0125-0Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/track/pdf/10.1186/s13024-016-0125-0Citation Count: 38
-
OPENTitle: A phenolic-rich extract from Ugni molinae berries reduces abnormal protein aggregation in a cellular model of Huntington’s diseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 16Issue #: 7Start Page: e0254834End Page: e0254834Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0254834Best OA location URL: https://doi.org/10.1371/journal.pone.0254834Citation Count: 11
-
OPENTitle: Decreased expression of CD200 and CD200 receptor in Alzheimer's disease: A potential mechanism leading to chronic inflammationJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 215Issue #: 1Start Page: 5End Page: 19Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2008.09.003Best OA location URL: http://doi.org/10.1016/j.expneurol.2008.09.003Citation Count: 240
-
OPENTitle: Differences in performance on English and Hebrew versions of the MoCA in Parkinson's patientsJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 3Issue #:Start Page: 100042End Page: 100042Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2020.100042Best OA location URL: https://doi.org/10.1016/j.prdoa.2020.100042Citation Count: 8
-
OPENTitle: A comprehensive screening of copy number variability in dementia with Lewy bodiesJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 75Issue #:Start Page: 223.e1End Page: 223.e10Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2018.10.019Best OA location URL: https://www.sciencedirect.com/science/article/pii/S019745801830383XCitation Count: 16
-
OPENTitle: Constructing de Novo H2O2 Signaling via Induced Protein ProximityJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 10Issue #: 6Start Page: 1404End Page: 1410Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschembio.5b00170Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4849873Citation Count: 16
-
OPENTitle: Generation of two human induced pluripotent stem cell lines (iPSCs) with mutations of the α-synuclein (SNCA) gene associated with Parkinson’s disease; the A53T mutation (LCSBi003) and a triplication of the SNCA gene (LCSBi007)Journal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 57Issue #:Start Page: 102600End Page: 102600Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.scr.2021.102600Best OA location URL: https://doi.org/10.1016/j.scr.2021.102600Citation Count: 0
-
OPENTitle: The Promise and Pitfalls of Facebook Advertising: a Genetic Counselor's PerspectiveJournal Name: Journal of Genetic CounselingPublisher: WileyVol: 27Issue #: 2Start Page: 326End Page: 328Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s10897-017-0207-3Citation Count: 5
-
RESTRICTEDTitle: Can We Treat Neurodegenerative Proteinopathies by Enhancing Protein Degradation?Journal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1346End Page: 1359Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29058Citation Count: 15